Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

Update: 2019-03-13

Description

In episode ten of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Caleb Banta-Green, principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions about subgroups that are more likely to take advantage of available interventions.

Read more here.

Comments

In Channel

Computerized CBT for Substance Use Disorders

2021-02-0213:36

Opioid Overdose in the Hospital Setting: A Systematic Review

2020-04-1613:14

Integrating Reproductive Health Services into Opioid Treatment Facilities

2020-01-2308:34

Technology Use Among Patients in Inpatient Medically Managed Withdrawal

2019-10-0812:42

Opioid Agonist Treatment in Postpartum Period During Incarceration

2019-07-2913:13

Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs

2019-05-2811:25

Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)

2019-04-0913:37

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

2019-03-1313:00

Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

2018-11-2711:38

Buprenorphine Treatment for Adolescents and Young Adults

2018-09-0617:09

Nicotine Content in E-cigarette liquid: often not as labeled

2018-06-2913:23

Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

2018-05-1511:58

Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

2018-04-0314:43

Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder

2018-01-0311:22

The Unexpected Urine Test: A Matter Far From Simple

2018-01-0314:47

Post-Cesarean Analgesia in Women on opioid agonists to treat Opiate Use Disorder

2017-12-1926:30

Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative

2025-09-1826:02

Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs

2025-08-2817:02

Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem

2025-07-1119:32

Post Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results

2025-06-2624:42

00:00

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

American Society of Addiction Medicine

#box-pro-ellipsis-175967809756715{-webkit-line-clamp:2;}Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

American Society of Addiction Medicine

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients